Description
Patanjali Divya Mahayograj Guggul is a well-known classical Ayurvedic formulation prepared using Guggul along with a combination of herbal and mineral ingredients. It is traditionally used to support joint health, nerve function, muscle strength and overall physical vitality. This formulation is commonly included in Ayurvedic wellness routines for individuals experiencing joint stiffness, body weakness or reduced mobility.
Mahayograj Guggul is known in Ayurveda for its balancing effect on Vata-related imbalances. Regular use may help support smoother joint movement, improved flexibility and better physical endurance. It is also traditionally used to support nerve strength and overall musculoskeletal health, making it beneficial for individuals with physically demanding lifestyles or age-related weakness.
Patanjali Divya Mahayograj Guggul tablets are prepared following classical Ayurvedic guidelines to maintain the authenticity and potency of the formulation. The tablet form makes it convenient for daily use as part of a structured wellness regimen.
Key Benefits
-
Supports joint comfort and flexibility
-
Helps manage stiffness and body weakness
-
Supports nerve and muscle strength
-
Promotes overall physical vitality
-
Classical Ayurvedic formulation
Ingredients
A traditional Ayurvedic blend containing Guggul along with herbal and mineral components such as Triphala, Trikatu and other classical ingredients. Please refer to the product packaging for the complete ingredient list.
Recommended Usage
Adults may take 1 to 2 tablets once or twice daily with lukewarm water or milk, or as directed by an Ayurvedic practitioner.
Precautions
-
Do not exceed the recommended dosage
-
Not recommended during pregnancy or breastfeeding without medical advice
-
Consult a physician if you have a medical condition or are taking medication
-
Keep out of reach of children
Storage Instructions
Store in a cool, dry place away from direct sunlight. Keep the container tightly closed after use.









Reviews
There are no reviews yet.